Yamina A. Berchiche, Ph.D.

Affiliations: 
2011 Université de Montréal, Montréal, Canada 
Area:
Biochemistry
Google:
"Yamina Berchiche"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Nikolaus Heveker grad student 2011 Université de Montréal
 (Etude de la relation entre les conformations et la signalisation des 7TMRs.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Schardien KA, Soto MS, Inbody L, et al. (2020) Investigation of G protein‐coupled receptor kinase 2 (GRK2) regulation of D 2 dopamine receptor signaling: effects of GRK2 functional domains and pharmacologic and genetic inhibition of GRK2 activity The Faseb Journal. 34: 1-1
Rico CA, Berchiche YA, Horioka M, et al. (2019) High-Affinity Binding of Chemokine Analogs that Display Ligand Bias at the HIV-1 Coreceptor CCR5. Biophysical Journal
Lorenzen E, Ceraudo E, Berchiche YA, et al. (2018) G protein subtype-specific signaling bias in a series of CCR5 chemokine analogs. Science Signaling. 11
Berchiche YA, Sakmar TP. (2016) CXC Chemokine Receptor 3 Alternative Splice Variants Selectively Activate Different Signaling Pathways. Molecular Pharmacology
Berchiche YA, Gravel S, Pelletier ME, et al. (2011) Different effects of the different natural CC chemokine receptor 2b ligands on beta-arrestin recruitment, Gαi signaling, and receptor internalization. Molecular Pharmacology. 79: 488-98
Berchiche YA, Chow KY, Lagane B, et al. (2011) Direct assessment of CXCR4 mutant conformations reveals complex link between receptor structure and Gα i activation (THe Journal of Biological Chemistry (2007) 282, (5111-5115)) Journal of Biological Chemistry. 286: 29440
Gravel S, Malouf C, Boulais PE, et al. (2010) The peptidomimetic CXCR4 antagonist TC14012 recruits beta-arrestin to CXCR7: roles of receptor domains. The Journal of Biological Chemistry. 285: 37939-43
Rafei M, Berchiche YA, Birman E, et al. (2009) An engineered GM-CSF-CCL2 fusokine is a potent inhibitor of CCR2-driven inflammation as demonstrated in a murine model of inflammatory arthritis. Journal of Immunology (Baltimore, Md. : 1950). 183: 1759-66
Kalatskaya I, Berchiche YA, Gravel S, et al. (2009) AMD3100 is a CXCR7 ligand with allosteric agonist properties. Molecular Pharmacology. 75: 1240-7
Rafei M, Berchiche Y, Wu JH, et al. (2008) 146 A GMCSF and CCL2 fusion chimera induces apoptosis in CCR2 expressing lymphomyeloid cells and promotes xenotolerance Cytokine. 43: 270
See more...